A human coronavirus evolves antigenically to escape antibody immunity
Preprint
Abstract
There is intense interest in antibody immunity to coronaviruses. However, it is unknown if coronaviruses evolve to escape such immunity, and if so, how rapidly. Here we address this question by characterizing the historical evolution of human coronavirus 229E. We identify human sera from the 1980s and 1990s that have neutralizing titers against contemporaneous 229E that are comparable to the anti-SARS-CoV-2 titers induced by SARS-CoV-2 infection or vaccination. We test these sera against 229E strains isolated after sera collection, and find that neutralizing titers are lower against these “future” viruses. In some cases, sera that neutralize contemporaneous 229E viral strains with titers >1:100 do not detectably neutralize strains isolated 8–17 years later. The decreased neutralization of “future” viruses is due to antigenic evolution of the viral spike, especially in the receptor-binding domain. If these results extrapolate to other coronaviruses, then it may be advisable to periodically update SARS-CoV-2 vaccines.Keywords
All Related Versions
- Published version: PLOS Pathogens, 17 (4), e1009453.
This publication has 78 references indexed in Scilit:
- MAFFT Multiple Sequence Alignment Software Version 7: Improvements in Performance and UsabilityMolecular Biology and Evolution, 2013
- Discordant antigenic drift of neuraminidase and hemagglutinin in H1N1 and H3N2 influenza virusesProceedings of the National Academy of Sciences, 2011
- Strength and tempo of selection revealed in viral gene genealogiesBMC Ecology and Evolution, 2011
- Viral Mutation RatesJournal of Virology, 2010
- Protease-Mediated Entry via the Endosome of Human Coronavirus 229EJournal of Virology, 2009
- Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivorsNature, 2008
- Phylogenetic Analysis Reveals the Global Migration of Seasonal Influenza A VirusesPLOS Pathogens, 2007
- Mapping the Antigenic and Genetic Evolution of Influenza VirusScience, 2004
- Identification of a new human coronavirusNature Medicine, 2004
- The time course of the immune response to experimental coronavirus infection of manEpidemiology and Infection, 1990